We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Lowering the Levels of Key Protein Might Be a Novel Way To Treat MS

News   Aug 13, 2020 | Original story from UT Southwestern Medical Center

 
Lowering the Levels of Key Protein Might Be a Novel Way To Treat MS
 
 
Advertisement
 

RELATED ARTICLES

Study Finds Unique Genetic Variants in ADHD Patients From Different Ethnic Backgrounds

News

Researchers from Children’s Hospital of Philadelphia (CHOP) have shown there may be key genetic differences in the causes of attention-deficit hyperactivity disorder (ADHD) between African Americans and people of European ancestry, which may play an important part in how patients of different ethnic backgrounds respond to treatments for this condition.

READ MORE

Study Investigates Racial Disparities in Clinical Trial Recruitment

News

Scientists are increasingly turning to electronic-based recruitment methods to encourage participation in clinical trials. Little is known about how this use of technology compares to more traditional clinical trial recruitment strategies, and some researchers worry that an overreliance on technology has the potential to exclude an eligible and interested diverse participant population.

READ MORE

Regular Doses of Awe Can Boost Emotional Wellbeing

News

A regular dose of awe is a simple way to boost healthy 'prosocial' emotions such as compassion and gratitude, according to a new study.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE